Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

GNPS Set of Amazonian fungal strains part 4

ABSTRACT: A set of fungal extract samples acquired with a micrOToF II instrument

INSTRUMENT(S): micrOTOF-Q II

ORGANISM(S): Fungi (ncbitaxon:4751)

SUBMITTER: Hector Koolen

PROVIDER: MSV000087814 | GNPS | Tue Jul 13 15:50:00 BST 2021

REPOSITORIES: GNPS

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

GNPS Set of Amazonian fungal strains part 4

Project description:A set os LCMS runs (micrOTOF II) with fungal extracts from different places of the Amazon

2021-07-12 | MSV000087802 | GNPS

GNPS Set of Amazonian fungal strains part 3

Project description:A data set of extracts analyzed with an Impact II instrument.

2021-07-12 | MSV000087799 | GNPS

GNPS Set of Amazonian fungal strains part 1

Project description:A single run with a QEXACTIVE instrument for a new Penicillium species.

2021-07-12 | MSV000087797 | GNPS

GNPS Data set of Amazonian Fungi 2 - Brazil

Project description:A set of LCMS data acquired in a micrOToF instrument (Bruker)

2021-07-09 | MSV000087788 | GNPS

GNPS Set of Amazonian fungal strains part 2

Project description:A set of files from fungi of different oringins from the Amazon region aquired in an iFunnel (Agilent)

2021-07-12 | MSV000087798 | GNPS

Fungal collection photosensitizers set

Project description:The present study was designed to test the hypothesis of a widespread photochemical trait in fruiting body-forming fungal species. The biomaterial was selected based on Gill and Steglich's classification of fungal pigments, which focuses on their biosynthetic origin. With the aim to cover most described pigment types, 48 different species were selected. Second, dried and ground fruiting bodies were extracted and subjected to UPLC-HRMS/MS measurement.

2022-02-01 | MSV000088756 | MassIVE

Fungal Metabologenomics 110 Strains

Project description:This dataset includes .mzXML MS profiles for 110 fungal strains each grown on 3 media conditions for used for integrated metabologenomics analysis. Data were collected on a Q Exactive mass spectrometer. Solvent blanks, media blanks, and technical replicates for a subset of strains are also included.

2022-07-07 | MSV000089848 | MassIVE

VVC-associated strains of Candida albicans provoke more fungal shedding and exfoliation than colonizing strains in epithelial cell infections

Project description:Vulvovaginal candidiasis (VVC) affects nearly ¾ of women during their lifetime and its symptoms seriously reduce quality of life. Although Candida albicans is a common commensal, it is unknown if VVC results from a commensal to pathogenic state switch, if only some strains can cause VVC, and/or if there is displacement of commensal strains with more pathogenic strains. We studied a set of VVC and Colonizing C. albicans strains to identify consistent in vitro phenotypes associated with one group or the other. We find that the strains do not differ in overall genetic profile or behavior in culture media (i.e. MLST profile, rate of growth, filamentation), but they show strikingly different behavior during their interactions with vaginal epithelial cells. Epithelial infections with VVC-derived strains yielded stronger fungal proliferation and shedding of fungi and epithelial cells. RNA-seq analysis of representative epithelial cell infections with selected pathogenic or commensal isolates identified several differentially activated epithelial signaling pathways, including the integrin, ferroptosis and type I interferon pathways; the latter has been implicated in damage protection. The type I interferon pathway is activated more by the Colonizing strains, while type I interferon inhibition selectively increases fungal shedding of only the colonizing fungi. These data suggest that VVC strains may intrinsically have more pathogenic potential via differential elicitation of epithelial responses, including type I interferon pathway. Therefore, it may be possible to evaluate pathogenic potential in vitro to refine VVC diagnosis.

2023-02-07 | GSE207081 | GEO